DCST2
gene geneOn this page
Also known as FLJ32934
Summary
DCST2 (DC-STAMP domain containing 2, HGNC:26562) is a protein-coding gene on chromosome 1q21.3, encoding DC-STAMP domain-containing protein 2 (Q5T1A1). Essential sperm cell-surface protein required for sperm-egg fusion and fertilization.
Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization and sperm-egg recognition. Predicted to be located in acrosomal membrane.
Source: NCBI Gene 127579 — RefSeq curated summary.
At a glance
- GWAS associations: 47
- Clinical variants (ClinVar): 184 total
- MANE Select transcript:
NM_144622
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26562 |
| Approved symbol | DCST2 |
| Name | DC-STAMP domain containing 2 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32934 |
| Ensembl gene | ENSG00000163354 |
| Ensembl biotype | protein_coding |
| OMIM | 619861 |
| Entrez | 127579 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding
ENST00000368423, ENST00000368424, ENST00000467991, ENST00000485982, ENST00000498036
RefSeq mRNA: 1 — MANE Select: NM_144622
NM_144622
CCDS: CCDS1082
Canonical transcript exons
ENST00000368424 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001073688 | 155031169 | 155031234 |
| ENSE00001073690 | 155032667 | 155032768 |
| ENSE00001073698 | 155033094 | 155033264 |
| ENSE00001073701 | 155030432 | 155030645 |
| ENSE00001073704 | 155031574 | 155031771 |
| ENSE00001852891 | 155018527 | 155018760 |
| ENSE00002176765 | 155033434 | 155033781 |
| ENSE00003458531 | 155029233 | 155029397 |
| ENSE00003476191 | 155023117 | 155023257 |
| ENSE00003484939 | 155026302 | 155026402 |
| ENSE00003497659 | 155030084 | 155030241 |
| ENSE00003500680 | 155023832 | 155023959 |
| ENSE00003522499 | 155026548 | 155026715 |
| ENSE00003565312 | 155023364 | 155023457 |
| ENSE00003606590 | 155024472 | 155024602 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 84.80.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0330 / max 18.6825, expressed in 8 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14891 | 0.0188 | 3 |
| 14893 | 0.0075 | 3 |
| 14894 | 0.0034 | 2 |
| 14892 | 0.0033 | 2 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 84.80 | gold quality |
| left testis | UBERON:0004533 | 83.90 | gold quality |
| skin of abdomen | UBERON:0001416 | 83.04 | gold quality |
| skin of leg | UBERON:0001511 | 81.41 | gold quality |
| testis | UBERON:0000473 | 80.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.23 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.49 | gold quality |
| zone of skin | UBERON:0000014 | 77.47 | gold quality |
| ectocervix | UBERON:0012249 | 75.39 | gold quality |
| tibial nerve | UBERON:0001323 | 75.12 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 74.16 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.11 | gold quality |
| endocervix | UBERON:0000458 | 73.95 | gold quality |
| minor salivary gland | UBERON:0001830 | 73.91 | gold quality |
| vagina | UBERON:0000996 | 73.86 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 73.62 | gold quality |
| esophagus mucosa | UBERON:0002469 | 72.54 | gold quality |
| granulocyte | CL:0000094 | 71.47 | gold quality |
| transverse colon | UBERON:0001157 | 71.05 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 70.53 | gold quality |
| mouth mucosa | UBERON:0003729 | 70.38 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 69.28 | gold quality |
| right uterine tube | UBERON:0001302 | 69.22 | gold quality |
| body of uterus | UBERON:0009853 | 69.05 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 68.99 | gold quality |
| left ovary | UBERON:0002119 | 68.89 | gold quality |
| cerebellar cortex | UBERON:0002129 | 68.80 | gold quality |
| body of stomach | UBERON:0001161 | 68.73 | gold quality |
| uterine cervix | UBERON:0000002 | 68.60 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.51 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8060 | no | 47.13 |
| E-ANND-3 | no | 2.20 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- OS9 is critically involved in the modulation of ER-to-Golgi transport of DC-STAMP in response to TLR triggering, suggesting a novel role for OS9 in myeloid differentiation and cell fusion. (PMID:18952287)
- This study highlights that common variation in DCST2 influences variation in early growth and adult height. (PMID:25281659)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dcst2 | ENSDARG00000088693 |
| mus_musculus | Dcst2 | ENSMUSG00000109293 |
| rattus_norvegicus | Dcst2 | ENSRNOG00000058618 |
| drosophila_melanogaster | CG6845 | FBGN0035099 |
| drosophila_melanogaster | CG32320 | FBGN0052320 |
Paralogs (3): OCSTAMP (ENSG00000149635), DCST1 (ENSG00000163357), DCSTAMP (ENSG00000164935)
Protein
Protein identifiers
DC-STAMP domain-containing protein 2 — Q5T1A1 (reviewed: Q5T1A1)
All UniProt accessions (2): H0YF62, Q5T1A1
UniProt curated annotations — full annotation on UniProt →
Function. Essential sperm cell-surface protein required for sperm-egg fusion and fertilization.
Subunit / interactions. Interacts with DCST1.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5T1A1-1 | 1 | yes |
| Q5T1A1-2 | 2 |
RefSeq proteins (1): NP_653223* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012858 | DC_STAMP-like | Domain |
| IPR051856 | CSR-E3_Ligase_Protein | Family |
| IPR058842 | DCST1_C | Domain |
Pfam: PF07782, PF26037, PF26039
UniProt features (22 total): topological domain 7, transmembrane region 6, glycosylation site 3, compositionally biased region 2, splice variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T1A1-F1 | 73.49 | 0.17 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 284, 296, 480
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOBP_SPERM_EGG_RECOGNITION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PLASMA_MEMBRANE_FUSION, GOBP_MEMBRANE_ORGANIZATION, GOBP_FERTILIZATION, GOBP_CELL_CELL_RECOGNITION, GOCC_ACROSOMAL_MEMBRANE, GOCC_SECRETORY_VESICLE, chr1q21, GOCC_SECRETORY_GRANULE_MEMBRANE
GO Biological Process (2): fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), sperm-egg recognition (GO:0035036)
GO Molecular Function (0):
GO Cellular Component (3): acrosomal membrane (GO:0002080), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| single fertilization | 2 |
| cellular process involved in reproduction in multicellular organism | 1 |
| cell-cell recognition | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DCST2 | SPACA6 | W5XKT8 | 747 |
| DCST2 | TMEM95 | Q3KNT9 | 688 |
| DCST2 | IZUMO1 | Q8IYV9 | 613 |
| DCST2 | PBXIP1 | Q96AQ6 | 478 |
| DCST2 | CLGN | O14967 | 472 |
| DCST2 | SPACA4 | Q8TDM5 | 441 |
| DCST2 | LENEP | Q9Y5L5 | 377 |
| DCST2 | ENTREP3 | P81408 | 370 |
| DCST2 | IZUMO1R | A6ND01 | 368 |
| DCST2 | LCN12 | Q6JVE5 | 367 |
| DCST2 | HAGHL | Q6PII5 | 355 |
| DCST2 | COBLL1 | Q53SF7 | 350 |
| DCST2 | SUMF1 | Q8NBK3 | 347 |
| DCST2 | FOLR2 | P14207 | 347 |
| DCST2 | SNX10 | Q9Y5X0 | 344 |
IntAct
0 interactions, top by confidence:
BioGRID (2): DCST2 (Affinity Capture-MS), DCST2 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LIJ0, A1L3G9, A4IFL1, B9X187, O18968, O70491, P08033, P08034, P28230, P35212, P36380, P51915, P60572, Q02738, Q059Y8, Q0V8E7, Q1LXZ7, Q28FG4, Q29559, Q4QR83, Q5E9Z5, Q5FVF4, Q5FWS4, Q5JW98, Q5R7B4, Q5T197, Q5T1A1, Q60HF7, Q640M6, Q6GMB1, Q6WGK6, Q7SY10, Q7TNJ0, Q8BXV2, Q8C2L6, Q8C9E8, Q8CE93, Q8CEG0, Q8N5C1, Q8NDZ6
Diamond homologs: A0A140LIJ0, Q5T1A1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
184 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 159 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2908 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:155030430:A:AC | donor_gain | 1.0000 |
| 1:155030431:C:CC | donor_gain | 1.0000 |
| 1:155032661:GCTTA:G | donor_loss | 1.0000 |
| 1:155032662:CTTAC:C | donor_loss | 1.0000 |
| 1:155032663:TTA:T | donor_loss | 1.0000 |
| 1:155032664:TAC:T | donor_loss | 1.0000 |
| 1:155032665:A:AC | donor_gain | 1.0000 |
| 1:155032666:C:CC | donor_gain | 1.0000 |
| 1:155032666:C:CT | donor_loss | 1.0000 |
| 1:155032666:CCTAT:C | donor_gain | 1.0000 |
| 1:155033087:GACTT:G | donor_loss | 1.0000 |
| 1:155033088:ACTTA:A | donor_loss | 1.0000 |
| 1:155033090:TTAC:T | donor_loss | 1.0000 |
| 1:155033091:TA:T | donor_loss | 1.0000 |
| 1:155033092:A:AC | donor_gain | 1.0000 |
| 1:155033092:A:C | donor_loss | 1.0000 |
| 1:155033093:C:A | donor_loss | 1.0000 |
| 1:155033093:C:CG | donor_gain | 1.0000 |
| 1:155033093:CT:C | donor_gain | 1.0000 |
| 1:155033093:CTG:C | donor_gain | 1.0000 |
| 1:155033093:CTGA:C | donor_gain | 1.0000 |
| 1:155033432:A:AC | donor_gain | 1.0000 |
| 1:155033433:C:CC | donor_gain | 1.0000 |
| 1:155023107:T:TA | donor_gain | 0.9900 |
| 1:155023363:CAG:C | donor_gain | 0.9900 |
| 1:155026296:CCTCA:C | donor_loss | 0.9900 |
| 1:155026297:CTCA:C | donor_loss | 0.9900 |
| 1:155026298:TCA:T | donor_loss | 0.9900 |
| 1:155026299:CA:C | donor_loss | 0.9900 |
| 1:155026301:C:A | donor_loss | 0.9900 |
AlphaMissense
4979 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:155031720:C:G | C198S | 0.992 |
| 1:155031721:A:T | C198S | 0.992 |
| 1:155033188:G:C | N115K | 0.991 |
| 1:155033188:G:T | N115K | 0.991 |
| 1:155030602:G:C | F283L | 0.989 |
| 1:155030602:G:T | F283L | 0.989 |
| 1:155030604:A:G | F283L | 0.989 |
| 1:155031687:C:G | C209S | 0.989 |
| 1:155031688:A:T | C209S | 0.989 |
| 1:155031720:C:T | C198Y | 0.989 |
| 1:155031588:C:G | C242S | 0.988 |
| 1:155031589:A:T | C242S | 0.988 |
| 1:155031688:A:G | C209R | 0.988 |
| 1:155031721:A:G | C198R | 0.988 |
| 1:155031588:C:T | C242Y | 0.987 |
| 1:155031589:A:G | C242R | 0.986 |
| 1:155033501:G:C | S67R | 0.983 |
| 1:155033501:G:T | S67R | 0.983 |
| 1:155033503:T:G | S67R | 0.983 |
| 1:155030603:A:G | F283S | 0.982 |
| 1:155029285:G:C | F430L | 0.981 |
| 1:155029285:G:T | F430L | 0.981 |
| 1:155029287:A:G | F430L | 0.981 |
| 1:155031219:C:T | C252Y | 0.981 |
| 1:155031621:C:T | C231Y | 0.981 |
| 1:155031622:A:G | C231R | 0.981 |
| 1:155030173:A:G | F363S | 0.979 |
| 1:155031219:C:G | C252S | 0.979 |
| 1:155031220:A:T | C252S | 0.979 |
| 1:155031719:G:C | C198W | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000459606 (1:155035634 AAG>A), RS1000511302 (1:155035228 TCTCAG>T), RS1000911822 (1:155023330 G>T), RS1000962254 (1:155022745 CAAACAAAACA>C,CAAACA,CAAACAAAACAAAACA), RS1001199649 (1:155029636 T>C), RS1001250372 (1:155029352 T>G), RS1001477850 (1:155029562 A>G), RS1001585934 (1:155022799 G>C), RS1001794559 (1:155035169 T>C), RS1002426642 (1:155028193 T>C), RS1002919916 (1:155019740 C>T), RS1003016361 (1:155019145 G>A), RS1003278663 (1:155020005 G>A,T), RS1003526149 (1:155024265 A>G), RS1003539466 (1:155031019 G>C,T)
Disease associations
OMIM: gene MIM:619861 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
47 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001942_19 | Prostate cancer | 2.000000e-08 |
| GCST002644_1 | Birth length | 2.000000e-08 |
| GCST002782_131 | Waist-to-hip ratio adjusted for body mass index | 5.000000e-10 |
| GCST002782_132 | Waist-to-hip ratio adjusted for body mass index | 7.000000e-10 |
| GCST002782_133 | Waist-to-hip ratio adjusted for body mass index | 3.000000e-10 |
| GCST002782_62 | Waist-to-hip ratio adjusted for body mass index | 3.000000e-10 |
| GCST004505_33 | Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) | 6.000000e-07 |
| GCST004505_34 | Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) | 2.000000e-06 |
| GCST007294_124 | Body fat distribution (trunk fat ratio) | 8.000000e-35 |
| GCST007294_3 | Body fat distribution (trunk fat ratio) | 6.000000e-21 |
| GCST007294_50 | Body fat distribution (trunk fat ratio) | 1.000000e-15 |
| GCST007295_17 | Body fat distribution (leg fat ratio) | 3.000000e-13 |
| GCST007295_37 | Body fat distribution (leg fat ratio) | 7.000000e-17 |
| GCST007295_72 | Body fat distribution (leg fat ratio) | 1.000000e-28 |
| GCST008103_81 | Bipolar disorder | 1.000000e-06 |
| GCST008362_141 | Birth weight | 7.000000e-11 |
| GCST008362_91 | Birth weight | 3.000000e-19 |
| GCST008363_17 | Offspring birth weight | 3.000000e-08 |
| GCST008363_22 | Offspring birth weight | 1.000000e-07 |
| GCST010242_258 | HDL cholesterol levels | 1.000000e-09 |
| GCST010303_17 | Nevus count or cutaneous melanoma | 2.000000e-18 |
| GCST010304_26 | Cutaneous malignant melanoma | 4.000000e-15 |
| GCST010696_19 | Cortical thickness (min-P) | 2.000000e-10 |
| GCST010697_10 | Cortical surface area (min-P) | 3.000000e-10 |
| GCST010698_59 | Subcortical volume (min-P) | 9.000000e-10 |
| GCST010699_20 | Brain morphology (min-P) | 7.000000e-10 |
| GCST010700_5 | Cortical thickness (MOSTest) | 8.000000e-17 |
| GCST010701_66 | Cortical surface area (MOSTest) | 1.000000e-09 |
| GCST010702_43 | Subcortical volume (MOSTest) | 3.000000e-10 |
| GCST010703_253 | Brain morphology (MOSTest) | 4.000000e-14 |
EFO canonical traits (15, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006784 | body height at birth |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0004318 | smoking behavior |
| EFO:0004341 | body fat distribution |
| EFO:0004344 | birth weight |
| EFO:0005939 | parental genotype effect measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004632 | nevus count |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
| EFO:0004327 | electrocardiography |
| EFO:0004980 | appendicular lean mass |
| EFO:0004842 | eosinophil count |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Sunitinib | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.